MARKET

GLAXF

GLAXF

GSK PLC
OTCPK
23.79
-1.71
-6.71%
Closed 14:03 09/09 EDT
OPEN
24.29
PREV CLOSE
25.50
HIGH
24.29
LOW
23.79
VOLUME
300
TURNOVER
7.19K
52 WEEK HIGH
29.56
52 WEEK LOW
19.31
MARKET CAP
96.24B
P/E (TTM)
15.21
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GLAXF last week (0831-0904)?
Weekly Report · 2d ago
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
Seeking Alpha · 08/31 14:50
Weekly Report: what happened at GLAXF last week (0824-0828)?
Weekly Report · 08/31 09:57
GSK: Still One Of My Top Healthcare Picks
Seeking Alpha · 08/27 12:08
Weekly Report: what happened at GLAXF last week (0817-0821)?
Weekly Report · 08/24 09:58
Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance
Seeking Alpha · 08/20 12:00
Weekly Report: what happened at GLAXF last week (0810-0814)?
Weekly Report · 08/17 09:58
Gilead Sciences: The Market May Be Underestimating Its Growth (Rating Upgrade)
Seeking Alpha · 08/10 13:16
More
About GLAXF
GSK plc is a United Kingdom-based biopharma company. The Company is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its segments include Commercial Operations and Research and Development. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) to antibiotics. It also owns ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody and HS235, a potential molecule for the treatment of pulmonary hypertension (PH). Its oncology portfolio also includes Zidesamtinib (NVL-520), neladalkib (NVL-655), and NVL-330. Its products include Anoro Ellipta, Apretude, Arexvy, Bexsero, Blenrep, Blujepa, Boostrix, Cervarix, Dovato, Efimosfermin, among others.

Webull offers GSK plc stock information, including OTCPK: GLAXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLAXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLAXF stock methods without spending real money on the virtual paper trading platform.